Nutrient regulation of signaling and transcription

GW Hart - Journal of Biological Chemistry, 2019 - ASBMB
In the early 1980s, while using purified glycosyltransferases to probe glycan structures on
surfaces of living cells in the murine immune system, we discovered a novel form of …

Post-translational modifications of intermediate filament proteins: mechanisms and functions

NT Snider, MB Omary - Nature reviews Molecular cell biology, 2014 - nature.com
Intermediate filaments (IFs) are cytoskeletal and nucleoskeletal structures that provide
mechanical and stress-coping resilience to cells, contribute to subcellular and tissue-specific …

Neurofilaments at a glance

A Yuan, MV Rao, RA Nixon - Journal of cell science, 2012 - journals.biologists.com
Neurofilaments (NFs) are intermediate filaments with a diameter of 10 nm, similar to that of
neurons. Although they are present in perikarya and dendrites, neurofilaments are …

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease

CX Gong, K Iqbal - Current medicinal chemistry, 2008 - ingentaconnect.com
Alzheimer disease (AD) is the most common cause of dementia in adults. The current
therapy for AD has only moderate efficacy in controlling symptoms, and it does not cure the …

The role of protein glycosylation in Alzheimer disease

S Schedin‐Weiss, B Winblad, LO Tjernberg - The FEBS journal, 2014 - Wiley Online Library
Glycosylation is one of the most common, and the most complex, forms of post‐translational
modification of proteins. This review serves to highlight the role of protein glycosylation in …

Mechanisms of tau-induced neurodegeneration

K Iqbal, F Liu, CX Gong, AC Alonso… - Acta …, 2009 - Springer
Alzheimer disease (AD) and related tauopathies are histopathologically characterized by a
specific type of slow and progressive neurodegeneration, which involves the abnormal …

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

F Liu, J Shi, H Tanimukai, J Gu, J Gu, I Grundke-Iqbal… - Brain, 2009 - academic.oup.com
It has been established for a long time that brain glucose metabolism is impaired in
Alzheimer's disease. Recent studies have demonstrated that impaired brain glucose …

An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease

C Clark, L Dayon, M Masoodi, GL Bowman… - Alzheimer's research & …, 2021 - Springer
Background Multiple pathophysiological processes have been described in Alzheimer's
disease (AD). Their inter-individual variations, complex interrelations, and relevance for …

O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond

SA Yuzwa, DJ Vocadlo - Chemical Society Reviews, 2014 - pubs.rsc.org
Alzheimer disease (AD) is a growing problem for aging populations worldwide. Despite
significant efforts, no therapeutics are available that stop or slow progression of AD, which …

The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways

Q Zeidan, GW Hart - Journal of cell science, 2010 - journals.biologists.com
A paradigm-changing discovery in biology came about when it was found that nuclear and
cytosolic proteins could be dynamically glycosylated with a single O-linked β-N …